Wellmedr vs bmiMD: Pricing, Shipping, and Plans Compared
Quick verdict: Wellmedr focuses on low starting prices and lifetime locked-in pricing for GLP-1 plans starting at $89/month, while bmiMD centers on compounded tirzepatide with multi-month pricing tiers that drop to $139/month for a 12-month plan. This comparison highlights the most distinctive differences so you can decide which fits your priorities.
Explore Wellmedr plans starting at $89/mo
Wellmedr vs bmiMD: key differences at a glance
This side-by-side looks at pricing and billing options, medication type and compounded status, shipping and refill policies, clinician review and access, and regulatory safety notes. Each claim below is taken from the providers’ published details and landing-page evidence.
| Criteria | Wellmedr | bmiMD |
|---|---|---|
| Starting price | Semaglutide from $89/mo; Semaglutide listed starting at $49/mo on some plans | Tirzepatide $179 month-to-month; $159 3-month; $149 6-month; $139 12-month |
| Billing options | Monthly plans with claims of lifetime locked-in pricing and no dose-based price increases | Four billing options with lower long-term monthly equivalent for multi-month plans |
| Medication type | Offers semaglutide and tirzepatide; mentions compounded GLP-1 medications from licensed U.S. pharmacies | Compounded tirzepatide (GLP-1/GIP) from state-licensed pharmacies |
| Shipping and refills | Same-day review plus free overnight shipping claimed; on-time refills guaranteed | Free subscription shipping on every order; online refills and delivery |
| Clinician review and access | All treatment plans require medical evaluation and clinician approval; same-day review claimed | 24/7 clinician access and online refills; treatment available only when a licensed clinician determines it is medically appropriate |
| Regulatory note | Compounded medications offered are not evaluated by the FDA for safety or efficacy | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality |
1. Pricing and billing options compared
Wellmedr advertises GLP-1 plans starting at $89/month, with marketing language about lifetime locked-in pricing, no dose-based price increases, and promotional offers captured on the landing page. bmiMD presents tirzepatide pricing that varies by term: $179 for month-to-month and as low as $139/month with a 12-month commitment. bmiMD explicitly lists four billing options and notes the lowest monthly equivalent requires a longer commitment.
See Wellmedr pricing and plan details
2. Medication types and compounded medication status
Both providers offer compounded GLP-1 therapies according to their landing information. Wellmedr lists semaglutide and tirzepatide and states its compounded GLP-1 medications come from licensed U.S. pharmacies while including a required safety notice that compounded medications are not evaluated by the FDA. bmiMD focuses on compounded tirzepatide and reiterates that compounded medications are not FDA-approved.
3. Shipping, refills, and turnaround
Wellmedr claims same-day review plus free overnight shipping and on-time refills guaranteed. bmiMD highlights free subscription shipping on every order and online refills with delivery. Both present shipping and refill features, but bmiMD emphasizes subscription free shipping and multi-month billing options that affect total prepaid charges.
Check bmiMD tirzepatide billing options
4. Clinician review and access
Wellmedr states all treatment plans require medical evaluation and clinician approval and captures claims of same-day review. bmiMD also requires a licensed clinician to determine medical appropriateness and advertises 24/7 clinician access. Both emphasize clinician oversight, but bmiMD calls out continuous access while Wellmedr highlights rapid review timing in its marketing content.
5. Safety and regulatory notes
Each provider includes regulatory language that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Wellmedr additionally includes a safety notice about GLP-1 medication risks such as thyroid C-cell tumors and MTC and advises seeking immediate care for specific symptoms. Wellmedr also frames some outcome language as reflecting published clinical research, not outcomes specific to the provider.
View bmiMD shipping and verification details
How to choose between Wellmedr and bmiMD
Choose based on what matters most from the providers’ published details. Wellmedr stands out for its low advertised starting price and marketing claims of lifetime locked-in pricing, same-day review, and on-time refills. bmiMD stands out for structured multi-month billing options, lower long-term monthly equivalents when you commit to longer terms, and free subscription shipping with 24/7 clinician access.
Start enrollment with Wellmedr
Choose Wellmedr if you prioritize lower advertised starting prices and locked-in pricing features. Choose bmiMD if you prioritize predictable multi-month pricing tiers, free subscription shipping, and around-the-clock clinician access. Remember all treatment is subject to clinician review and compounded medications are not FDA-approved.